TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
3.330
+0.030 (0.91%)
Feb 21, 2025, 4:00 PM EST - Market closed
TuHURA Biosciences Employees
TuHURA Biosciences had 1 employees as of December 31, 2023.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$19,333,782
Market Cap
140.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
HURA News
- 3 days ago - TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Accesswire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders - GlobeNewsWire
- 2 months ago - TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc. - Accesswire
- 3 months ago - TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update - Accesswire
- 4 months ago - TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - Accesswire
- 4 months ago - TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event - Accesswire
- 4 months ago - TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Accesswire
- 4 months ago - Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 - PRNewsWire